Roles of μ-opioid receptors and nociceptin/orphanin FQ peptide receptors in buprenorphine-induced physiological responses in primates

CM Cremeans, E Gruley, DJ Kyle, MC Ko - Journal of Pharmacology and …, 2012 - ASPET
Buprenorphine is known as a μ-opioid peptide (MOP) receptor agonist, but its
antinociception is compromised by the activation of nociceptin/orphanin FQ peptide (NOP) …

Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/μ-opioid receptor agonists

TV Khroyan, WE Polgar, F Jiang, NT Zaveri… - Journal of Pharmacology …, 2009 - ASPET
Activation of brain nociceptin/orphanin FQ (NOP) receptors leads to attenuation of μ-opioid
receptor (MOP receptor)-mediated antinociception. Buprenorphine, a high-affinity partial …

Buprenorphine-induced antinociception is mediated by μ-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors

K Lutfy, S Eitan, CD Bryant, YC Yang… - Journal of …, 2003 - Soc Neuroscience
Buprenorphine is a mixed opioid receptor agonist-antagonist used clinically for maintenance
therapy in opiate addicts and pain management. Dose-response curves for buprenorphine …

[HTML][HTML] Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys

MC Ko, JH Woods, WE Fantegrossi… - …, 2009 - nature.com
Behavioral effects of a nonpeptidic NOP (nociceptin/orphanin FQ Peptide) receptor agonist,
Ro 64-6198, have not been studied in primate species. The aim of the study was to verify the …

Buprenorphine exerts its antinocicepttve activity via μ1-opioid receptors

J Kamei, A Saitoh, T Suzuki, M Misawa, H Nagase… - Life sciences, 1995 - Elsevier
The mechanism of the antinociceptive effect of buprenorphine was assessed by
administering selective μ-, μ1-, δ-and κ-opioid receptor antagonists in mice. Intraperitoneal …

Therapeutic potentials of NOP and MOP receptor coactivation for the treatment of pain and opioid abuse

N Kiguchi, H Ding, MC Ko - Journal of neuroscience research, 2022 - Wiley Online Library
Following the identification of the nociceptin/orphanin FQ (N/OFQ) peptide (NOP) as an
endogenous ligand for the NOP receptor, ample evidence has revealed unique functional …

Pharmacological characterization of the newly synthesized nociceptin/orphanin FQ–receptor agonist 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H …

A Hirao, A Imai, Y Sugie, Y Yamada, S Hayashi… - Journal of …, 2008 - Elsevier
Nociceptin/orphanin FQ peptide (NOP)-receptor agonists have been shown to produce
anxiolytic-like effects in rodents subjected to various behavioral assays. Recently, we …

A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates

H Ding, N Kiguchi, D Yasuda, PR Daga… - Science translational …, 2018 - science.org
Misuse of prescription opioids, opioid addiction, and overdose underscore the urgent need
for developing addiction-free effective medications for treating severe pain. Mu opioid …

The first universal opioid ligand,(2S)-2-[(5R, 6R, 7R, 14S)-N-cyclopropylmethyl-4, 5-epoxy-6, 14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3, 3-dimethylpentan-2 …

TV Khroyan, WE Polgar, G Cami-Kobeci… - … of Pharmacology and …, 2011 - ASPET
Certain behavioral features of buprenorphine, including a bell-shaped curve for
antinociception and attenuation of alcohol consumption, are thought to be mediated by …

Nociceptin/orphanin FQ peptide receptor-related ligands as novel analgesics

N Kiguchi, H Ding, S Kishioka… - Current topics in medicinal …, 2020 - ingentaconnect.com
Despite similar distribution patterns and intracellular events observed in the
nociceptin/orphanin FQ peptide (NOP) receptor and other opioid receptors, NOP receptor …